Filing Flows › GoodRx Holdings (GDRX) › Q1 2026
GoodRx Holdings (GDRX) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 6, 2026
GoodRx Holdings (GDRX) reported revenue of $194M for the first quarter 2026 (Q1 2026), -4% from a year earlier and -0.4% from the quarter before. Operating margin was 7.2%, net earnings $1.2M (0.6% of revenue).
GoodRx Holdings, Q1 2026: revenue $194M (-4% year over year), operating margin 7.2%, net earnings $1.2M, operating cash flow $11.8M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $194M | -0.4% | -4% |
| Operating profit | $14.0M | -38% | -40% |
| Net earnings | $1.2M | -78% | -89% |
| Operating cash flow | $11.8M | -64% | +26% |
| Free cash flow | $10.7M | -66% | +15% |
What changed
Revenue was $194.0M in Q1 2026, down 4% year over year and roughly flat from the previous quarter. Prescription transactions revenue was the largest line at 59% of revenue. Prescription transactions revenue lost $35.2M year over year (down 24%), 393% of the total change.
Operating profit was $14.0M, a 7.2% margin (down 4.3 points year over year). Total costs grew 0% against a revenue fall of 4%. The fastest-growing cost line was Cost of revenue (+51%). Net earnings were $1.2M, down 89% year over year. The effective tax rate was 79.3%.
Operating cash flow was $11.8M (up 26% year over year), 1013% of net earnings. Non-cash charges added back $21.8M of depreciation and amortization and $16.5M of share-based compensation. Working capital and other items used $27.6M. Capital expenditures of $1.1M left free cash flow of $10.7M.
Questions
What was GoodRx Holdings' revenue in the first quarter 2026?
GoodRx Holdings (GDRX) reported revenue of $194M for the first quarter 2026 (Q1 2026), -4% from a year earlier and -0.4% from the quarter before.
Was GoodRx Holdings profitable in the first quarter 2026?
Operating profit was $14.0M (7.2% of revenue) and net earnings $1.2M.
Source: GoodRx Holdings 10-Q on SEC EDGAR.